- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 104 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- November 2020
- 260 Pages
Global
From €2409EUR$2,750USD£2,090GBP
- Report
- November 2023
- 171 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- July 2021
- 111 Pages
Global
From €4160EUR$4,750USD£3,611GBP
Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is a member of the COX-2 inhibitor class of analgesics, which are used to treat pain and inflammation without the risk of gastrointestinal side effects associated with other NSAIDs. Celebrex is used to treat a variety of conditions, including arthritis, menstrual cramps, and acute pain. It is also used to reduce the risk of colorectal polyps in people with familial adenomatous polyposis.
Celebrex is available in both brand-name and generic forms. It is available in capsule form and is taken orally. The dosage and frequency of use depend on the condition being treated.
Celebrex is a widely used analgesic, and is one of the most prescribed drugs in the United States. It is available in many countries around the world, and is used to treat a variety of conditions.
Companies in the Celebrex market include Pfizer, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more
